ERSOY, Mustafa. Can Immature Granulocytes Guide Chemotherapy Decisions in Later Lines of Therapy for HER2-Negative Breast Cancer?. The European Research Journal, [S. l.], v. 12, n. 1, p. 86–96, 2026. DOI: 10.18621/eurj.1764519. Disponível em: https://eurj.org.tr/article/view/1113. Acesso em: 5 apr. 2026.